STS Score: How Surgeons Estimate Your Surgical Risk

What Is the STS Score Surgical Risk Model?

The STS Score surgical risk calculator is a statistical tool developed by the Society of Thoracic Surgeons to estimate the likelihood of complications or death after cardiac surgery. When your surgeon tells you that your risk is, for example, three percent, that number typically comes from this model. It draws on data from hundreds of thousands of real operations recorded in the STS National Database, making it one of the most evidence-based risk-prediction instruments in modern medicine. The score is expressed as a percentage, representing the estimated probability of a specific outcome — most commonly mortality — within thirty days of surgery.

What outcomes does the STS Score predict? The calculator can estimate several endpoints, not just survival. These include operative mortality, stroke, renal failure, prolonged ventilation, deep sternal wound infection, and reoperation. When your cardiac team references your STS Score surgical risk, they may be looking at a composite of these individual probabilities or a combined figure. Each endpoint uses a slightly different set of weighted variables, so a patient might have a low mortality risk but a higher risk of prolonged ventilation, for instance. Understanding which specific outcome the score refers to matters more than knowing a single number.

Why was the STS Score created? Before standardised risk models existed, surgeons relied on clinical judgement alone, which varied widely from one institution to another. The STS Score was built to bring objectivity and consistency to preoperative counselling. By comparing your profile against outcomes of similar patients, the tool helps your team give you a realistic — neither optimistic nor alarmist — picture of what to expect. For patients considering procedures in Mexico or travelling internationally for cardiac care, knowing this score gives you a common language to discuss risk with any qualified cardiac team, as referenced by Johns Hopkins Medicine.

How Surgeons Use the STS Score to Plan Your Surgery

Your cardiac surgeon does not look at the STS Score surgical risk in isolation. Instead, they fold it into a broader preoperative assessment that includes imaging, laboratory values, functional status, and your overall clinical narrative. The score serves as a starting point — a quantified baseline — that the surgeon then adjusts based on factors the calculator may not fully capture, such as the quality of your Ascending Aorta tissue or the severity of calcification around your valve. This combined approach, blending data with experience, is what allows a surgeon to recommend the approach with the lowest risk for your situation.

How does the score change the surgical plan? If your STS Score comes back higher than expected, your team may reconsider the operative strategy. For example, a patient with a high predicted risk of mortality might be steered toward a less invasive approach or a transcatheter intervention rather than open surgery. The score can also influence decisions about intraoperative support — whether you will need an Arterial Line for continuous blood-pressure monitoring, whether Autologous Blood should be collected preoperatively, or whether Awake ECMO might be considered in select high-risk scenarios. Each of these decisions is tailored to reduce the specific risks the score highlights.

The score also plays a role in timing. If your calculated risk is elevated because of a modifiable condition — say, an active infection or poorly controlled diabetes — your surgeon may recommend delaying the procedure until that factor is addressed. In complex cases, such as those involving infective endocarditis with extensive valve damage, a staged approach may be safer than a single operation, as illustrated in a Successful treatment of challenging case of infective endocarditis report. The STS Score gives the team a measurable way to track whether preoperative optimisation is actually reducing your predicted risk over time.

What Factors Influence Your STS Score Surgical Risk?

The calculator incorporates dozens of variables, but they fall into several major categories: demographic factors, comorbidities, cardiac anatomy, and the planned procedure itself. Age, body mass index, and gender form the demographic baseline. Comorbidities such as diabetes, chronic lung disease, renal dysfunction, and previous stroke all push the score upward. Cardiac-specific factors include the urgency of the operation (elective, urgent, emergent, or salvage), the presence of Atheromatous Plaque in the aorta, and whether you have had prior cardiac surgery. The type of procedure — isolated valve, isolated coronary artery bypass, or combined — also carries different baseline risk weights.

Which comorbidities carry the most weight? Renal function is among the strongest predictors. A patient on dialysis faces a substantially higher operative risk than one with normal creatinine, and the STS Score reflects this prominently. Chronic obstructive pulmonary disease and active heart failure also contribute significantly. Less obvious but still important are factors like a history of Atrial Flutter or other arrhythmias, peripheral vascular disease, and the use of certain medications such as Aspirin, which the calculator accounts for in its anticoagulation and bleeding-risk modules. Your surgeon will review these variables with you in detail during the preoperative consultation.

• Cardiac status: Ejection fraction below 40%, recent heart failure, or haemodynamic instability increase risk substantially.
• Renal function: Creatinine clearance and dialysis dependence are among the heaviest-weighted comorbid variables.
• Pulmonary disease: Moderate or severe COPD reduces postoperative ventilator-weaning capacity.
• Operative urgency: Emergent and salvage operations carry far higher risk than elective, planned cases.

How does the planned procedure affect the score? The STS Score is procedure-specific. A combined coronary artery bypass and valve replacement carries a higher baseline risk than an isolated valve operation. If your surgeon plans to use an Arterial Graft for bypass, the model accounts for the different patency and complication profile compared to venous grafts. Similarly, the choice between a Balloon-expandable Valve and a self-expanding valve in transcatheter contexts involves different anatomical risk considerations, though the classic STS Score is primarily designed for open surgical procedures. Your surgical team will explain which version of the calculator applies to your specific operation.

STS Score vs EuroSCORE II: Which Risk Model Matters for You?

Patients often hear two different risk percentages from their cardiac team: one from the STS Score and another from EuroSCORE II. These are the two most widely used surgical risk calculators in the world, and while they share many variables, they produce different numbers because they were built from different patient populations and use different statistical methods. The STS Score draws on North American data, while EuroSCORE II is based on European surgical outcomes. Neither is inherently more accurate; each reflects the population and surgical practices of its source database.

Why might the two scores differ for the same patient? EuroSCORE II tends to produce slightly higher risk estimates than the STS Score for many patient profiles, partly because of differences in how certain variables are defined and weighted. For instance, EuroSCORE II places significant weight on the New York Heart Association functional class and on pulmonary artery pressure, whereas the STS Score incorporates more granular renal function data and operative urgency categories. A patient with moderate renal impairment and good functional status might receive a lower STS Score but a higher EuroSCORE II, or vice versa. Your surgeon will interpret both in context rather than choosing one as definitive.

The practical takeaway is that no single number should drive your decision. Both calculators are tools to support — not replace — clinical judgement. Your surgeon may use the STS Score as the primary instrument and EuroSCORE II as a cross-check, especially for complex or unusual cases. The important question is not which score is lower, but whether both scores, combined with your surgeon's experience and your own preferences, point toward the same operative plan. If the scores diverge significantly, that itself is a signal to discuss the reasons with your team in detail.

How Age and Frailty Affect Your STS Score Surgical Risk

Chronological age is a straightforward input in the STS Score, but biological age — what your body can actually tolerate — is far more nuanced. Two patients of the same calendar age can have dramatically different surgical risk profiles depending on fitness, muscle mass, nutritional status, and cognitive function. This gap between calendar age and physiological reserve is where the concept of frailty becomes critical, and it is an area where the STS Score, while improving, still has limitations. The calculator incorporates age as a continuous variable, but frailty is harder to capture in a single number.

How is frailty assessed alongside the STS Score? Many cardiac surgery programmes now perform a formal frailty assessment in addition to the STS Score. This may include grip-strength testing, gait-speed measurement, and questionnaires about independence in daily activities. A patient who scores well on the STS Score but shows clear signs of frailty — unintentional weight loss, exhaustion, slow walking speed — may face a higher real-world risk than the calculator predicts. Surgeons increasingly view these two assessments as complementary: the STS Score estimates procedural risk, while frailty assessment estimates the patient's capacity to recover from that risk.

Older patients should not assume that age alone disqualifies them from surgery. Guidelines do not set an upper age limit for cardiac operations; decisions are driven by overall risk-benefit analysis. For example, a fit seventy-eight-year-old with a well-controlled single-vessel lesion may be an excellent candidate, while a frail sixty-five-year-old with multiple comorbidities may face a steeper recovery. The published literature, including case reports such as the Eyes wide shut - unusual two stage repair of pectus excavatum and annuloaortic ectasia in a 37 year old marfan patient, demonstrates that risk models must always be interpreted in the context of individual anatomy and physiology, not age alone.

What Your STS Score Means for Recovery Timeline

Your STS Score surgical risk does not only predict what happens in the operating room; it also correlates with your recovery trajectory. Patients with higher scores tend to experience longer intensive care unit stays, more days on a ventilator, and a greater need for postoperative rehabilitation. This does not mean recovery will be impossible or that outcomes will be poor — many high-risk patients recover fully — but it does mean the timeline may be longer and the milestones different from those of a low-risk patient. Setting realistic expectations before surgery helps reduce anxiety and improves adherence to the recovery plan.

What recovery milestones should high-risk patients expect? A patient with an elevated STS Score may spend several additional days in the ICU compared to a low-risk counterpart. Extubation may take longer, and temporary inotropic support (medications that strengthen heart contractions) may be needed. Early mobilisation — sitting on the edge of the bed, then walking short distances — remains a goal, but the pace is individualised. If Auscultation reveals persistent lung congestion or if the heart rhythm shows instability such as Atrial Flutter, the team may extend monitoring before transferring you to a standard ward. Each of these steps is a normal part of high-risk postoperative care, not a sign of failure.

Discharge planning begins before surgery, and your STS Score helps shape that plan. High-risk patients may be referred to a cardiac rehabilitation programme immediately after discharge, or a longer inpatient stay may be arranged. For international patients travelling to Mexico for surgery, this planning also includes decisions about when it is safe to fly home, how to manage follow-up imaging remotely, and how to coordinate care with local cardiologists. Understanding your score allows you and your family to prepare logistically and emotionally for the recovery that lies ahead, rather than being surprised by a timeline that differs from the "typical" six-to-eight-week narrative.

Can You Lower Your STS Score Before Heart Surgery?

Some components of the STS Score surgical risk are fixed — age, gender, prior surgeries — but others are modifiable. If your surgery is elective or semi-elective, your cardiac team may recommend a period of preoperative optimisation to reduce specific risk factors. This is not about gaming the score; it is about genuinely improving your physiological condition so that you face the operation in the best possible shape. The extent to which you can lower your score depends on which variables are elevated and how much time you have before the procedure.

Which modifiable factors make the biggest difference? Smoking cessation is among the most impactful. Stopping even four to six weeks before surgery reduces respiratory complications and improves wound healing. Glycaemic control in diabetic patients, treatment of active infections, and optimisation of heart failure medications can all shift your risk profile. If your Apolipoprotein B levels indicate poorly controlled atherosclerosis, your team may intensify lipid-lowering therapy. For patients on medications like those studied in the ARISTOTLE trial, anticoagulation management must be carefully coordinated to minimise bleeding risk during surgery. Your surgeon will identify which factors offer the most improvement potential for your specific case.

• Smoking cessation: Stopping 4–6 weeks preoperatively reduces pulmonary complications and wound infection risk.
• Glycaemic control: Tight blood-sugar management before surgery lowers infection rates and improves healing.
• Medication optimisation: Adjusting heart failure and anticoagulation regimens under medical supervision can reduce intraoperative bleeding and arrhythmia risk.

It is important to understand that preoperative optimisation has limits. Some conditions cannot be reversed quickly, and attempting aggressive interventions right before surgery may itself introduce risk. Your cardiac team will weigh the benefit of waiting against the risk of delaying treatment of your underlying cardiac problem. In some cases, the disease process — for instance, a rapidly worsening valve lesion or an Atheromatous Plaque at risk of rupture — may make waiting more dangerous than proceeding. The decision is always individualised, and the STS Score helps quantify whether the waiting period is actually reducing the risk meaningfully.

When the STS Score Recommends a Different Procedure

Sometimes the STS Score surgical risk calculation reveals that the operation you originally discussed may not be the safest option. This is not a rejection — it is a redirection. If your score for an open surgical valve replacement comes back high, your surgeon may recommend transcatheter aortic valve replacement (TAVR) as an alternative, particularly if you are older or have comorbidities that make sternotomy riskier. Similarly, a high score for combined valve and bypass surgery might lead your team to recommend a staged approach, addressing one problem first and reassessing the other after recovery. The goal is always to find the lowest-risk effective treatment for your situation.

How does the STS Score influence the choice between surgery and TAVR? The score provides a quantitative basis for what was historically a subjective judgement. Patients with a high STS Score and specific anatomical criteria — such as a heavily calcified Ascending Aorta that would make clamping dangerous — may be better candidates for a transcatheter approach, where the valve is delivered via a catheter rather than through open chest surgery. In some centres, a prior Balloon Aortic Valvuloplasty may be performed as a bridge or diagnostic step to assess how the heart responds to relief of the stenosis before a definitive valve intervention. The STS Score is one input in this decision, not the sole determinant.

For coronary disease, a high STS Score may shift the conversation from surgical bypass to percutaneous intervention, or vice versa, depending on anatomy and diabetes status. If you have had a previous Atypical Infarction or present with Arm Pain that suggests atypical cardiac ischaemia, the diagnostic workup becomes more complex and the risk model must account for that uncertainty. The key message is that a high score does not mean "no treatment" — it means the treatment plan needs to be thoughtfully adjusted. Your surgeon will explain why a different approach may offer a better balance of benefit and risk, and what evidence supports that recommendation.

How to Discuss Your STS Score With Your Cardiac Team

Many patients feel overwhelmed when they hear a percentage associated with their surgery. A score of five percent sounds frightening if you do not know what it means in context. The first question to ask your surgeon is what specific outcome the percentage refers to — mortality, stroke, renal failure, or a composite. The second question is how the score compares to average risk for patients of your age and condition. A five percent mortality risk might be average for an eighty-year-old undergoing combined valve and bypass surgery, or it might be unusually high for a sixty-year-old having an isolated valve replacement. Context changes everything.

What questions help you understand your score? Ask whether your score places you in a low-, intermediate-, or high-risk category for your specific procedure. Ask what factors are driving the score upward and which of those are modifiable. Ask whether the team calculated both STS Score and EuroSCORE II, and whether they agree. Ask what the surgeon's own institutional outcomes are for your procedure — because the STS Score is a population average, and your surgical centre's actual results may be better or worse than that average. These conversations give you a clearer picture than any single number printed on a page.

For patients considering treatment internationally — for example, travelling to Guadalajara, Querétaro, or Hermosillo for surgery — the STS Score offers a universal reference point. You can share your calculated score with your local cardiologist and your surgical team in Mexico, and both sides will understand the same risk language. This transparency supports continuity of care across borders. When you meet with Dr Molina's team, bring your complete medical records, imaging studies, and any prior risk calculations. A consultation is not just about receiving a recommendation; it is about understanding the reasoning behind it, and the STS Score is a central part of that reasoning.

STS Score and Shared Decision-Making in Cardiac Surgery

Modern cardiac surgery has moved away from a paternalistic model — where the surgeon simply tells you what to do — toward shared decision-making, where you and your team weigh the risks and benefits together. The STS Score surgical risk is a cornerstone of this process because it gives both sides a common, quantified starting point. When you understand your score, you can participate meaningfully in decisions about procedure choice, timing, and acceptable trade-offs. This is especially important for patients facing complex choices, such as whether to proceed with surgery at all or to continue with medical management.

How does shared decision-making work in practice? Your surgeon presents the score, explains the variables driving it, and outlines the available options. You then discuss your own values: What level of risk is acceptable to you? Would you prefer a smaller chance of a major complication even if it means a longer or less definitive treatment? Are there quality-of-life considerations that weigh more heavily than statistical survival? For some patients, avoiding a large chest incision is a priority; for others, durability of the repair matters more. The STS Score cannot answer these questions for you, but it gives you the data framework to explore them with confidence.

Shared decision-making does not end when you sign the consent form. It continues through preoperative optimisation, the operation itself, and the recovery period. If your score changes because a modifiable factor improves, or if new information emerges — such as imaging that reveals unexpected Atheromatous Plaque or an Atypical Infarction on preoperative testing — the plan may be revised. The goal is not to follow a rigid path but to keep adjusting toward the best outcome for your individual circumstances. If you are considering cardiac surgery, the most important step you can take is to book a consultation with a qualified cardiac team who can calculate your STS Score, explain it in plain language, and help you make a decision grounded in evidence rather than fear. Self-diagnosis or self-assessment of risk is never appropriate; every score must be interpreted by a clinician who knows your full story.

Closing Thoughts

Understanding your STS Score surgical risk transforms an intimidating number into a practical tool for planning your cardiac care. The score does not define your fate — it estimates probabilities so that you and your surgeon can make informed decisions together. Whether your risk is low or elevated, the path forward involves the same steps: thorough evaluation, honest discussion, and a treatment plan tailored to your anatomy, your comorbidities, and your personal priorities. If you or a family member is facing cardiac surgery, we encourage you to schedule a consultation with our team at Cirugía de Corazón. Dr Alejandro Molina and his colleagues in Guadalajara, Querétaro, and Hermosillo will review your complete clinical picture, calculate your surgical risk using established models, and walk you through every option with clarity and compassion. The right decision begins with the right conversation — and that conversation should happen with a qualified cardiac team, not alone.